IN-DATE
90312: Stryker Trevo NXT ProVue Retriever 3mm x 32/36mm x 200cm, 0.015"
Sign in to add this product to your favorites!
| Price: | $999.00 $499.50 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 28 box of 1 |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 9 hours 41 minutes and choose overnight shipping at checkout. |
Related Items
QUICK VIEW
| 90314 - Size: 4.00mm $999.00 $499.50 per box of 1 Stryker Trevo NXT ProVue Retriever 4mm x 41/44mm x 200cm, 0.019" Expired Units in stock: 24 box of 1 | Order Qty |
|
QUICK VIEW
| 90315 - Size: 6.00mm $999.00 $499.50 per box of 1 Stryker Trevo NXT ProVue Retriever 6mm x 37/40mm x 200cm, 0.019" Expired Units in stock: 30 box of 1 | Order Qty |
|
QUICK VIEW
| 90313 - Size: 4.00mm $999.00 $299.70 per box of 1 Stryker Trevo NXT ProVue Retriever 4mm x 28/32mm x 200cm, 0.019" Expired Units in stock: 10 box of 1 | Order Qty |
QUICK VIEW
| 90183 - Size: 3.00mm $705.50 per box of 1 Stryker Trevo XP ProVue Retriever 3mm x 20mm Expired Units in stock: 7 box of 1 | Order Qty |
Additional Details
Stryker 90312 Trevo NXT ProVue Retriever, 3 mm × 32 mm
The Stryker 90312 Trevo NXT ProVue Retriever is a self-expanding neurovascular thrombectomy device designed for mechanical clot retrieval during endovascular treatment of acute ischemic stroke. The 3 mm × 32 mm retriever is delivered through a compatible microcatheter and is intended for use in intracranial vessels during neurointerventional thrombectomy procedures.
Product Code: 90312
- Manufacturer: Stryker
- Product Name: Trevo NXT ProVue Retriever
- Product Family: Trevo NXT
- Device Type: Neurovascular stent retriever
- Device Diameter: 3 mm
- Device Length: 32 mm
- Working Length: 200 cm
- Distal Wire Diameter: 0.015 in.
- Clinical Application: Mechanical thrombectomy for acute ischemic stroke
- Procedure Type: Endovascular clot retrieval
- Specialty: Neurointerventional Surgery
- Anatomical Application: Intracranial vasculature
- Compatibility: Trevo Pro 14 Microcatheter, Trevo Trak 21 Microcatheter
- Implantable: No
Features
- Self-expanding retriever designed for mechanical clot engagement and removal
- ProVue construction supports fluoroscopic visualization during thrombectomy
- 3 mm diameter configuration is intended for smaller intracranial vessels
- Compatible with Trevo Pro 14 and Trevo Trak 21 microcatheters
Sterilization
- Device Packaged as Sterile: Yes
- Requires Sterilization Prior to Use: No
- Single-Use, Disposable
AccessGUDID Info
- FDA Product Code: NRY
- FDA Product Code Name: CATHETER, THROMBUS RETRIEVER
- FDA Product Code: POL
- FDA Product Code Name: Neurovascular Mechanical Thrombectomy Device for Acute Ischemic Stroke Treatment
- GMDN Term Code: 58173
- GMDN Term Name: Thrombectomy suction catheter
- GMDN Term Description: A flexible or semi-flexible tube designed for the percutaneous, transluminal disruption and removal of clotted blood (i.e., a thrombus or thromboembolus) or other formed elements causing vascular obstruction in native/stented blood vessels, native/synthetic bypass grafts, and/or haemodialysis access grafts, through suction (aspiration) in conjunction with a syringe or dedicated suction pump system (pump not included). It may additionally be intended for infusion of fluids and/or used as a guide-catheter to facilitate introduction of a thrombectomy wire-net (not included) to remove residual thrombus. Collection containers may be included with the catheter. This is a single-use device.
Manufacturer
Stryker Neurovascular is a global leader in stroke care and neurointervention, offering a comprehensive portfolio of devices for the treatment of ischemic and hemorrhagic stroke. Their product lines include the Trevo Retriever for mechanical thrombectomy, the AXS Infinity and AXS Catalyst distal access catheters, and the Target coil family for aneurysm embolization. Stryker also offers the Neuroform Atlas and LVIS stents for stent-assisted coiling, as well as the Surpass Evolve flow diverter for treating large or wide-neck intracranial aneurysms. With a focus on rapid innovation, clinical outcomes, and stroke workflow optimization, Stryker Neurovascular continues to shape the future of minimally invasive neurosurgery.
